120 related articles for article (PubMed ID: 17141530)
1. Early evaluation of compound QT prolongation effects: a predictive 384-well fluorescence polarization binding assay for measuring hERG blockade.
Deacon M; Singleton D; Szalkai N; Pasieczny R; Peacock C; Price D; Boyd J; Boyd H; Steidl-Nichols JV; Williams C
J Pharmacol Toxicol Methods; 2007; 55(3):238-47. PubMed ID: 17141530
[TBL] [Abstract][Full Text] [Related]
2. Use of high throughput ion channel profiling and statistical modeling to predict off-target arrhythmia risk - One pharma's experience and perspective.
Watt ED; Lee T; Feng SL; Kilfoil P; Ackley D; Keefer C; Wisialowski T; Jenkinson S
J Pharmacol Toxicol Methods; 2022; 118():107213. PubMed ID: 36084863
[TBL] [Abstract][Full Text] [Related]
3. hERG subunit composition determines differential drug sensitivity.
Abi-Gerges N; Holkham H; Jones EM; Pollard CE; Valentin JP; Robertson GA
Br J Pharmacol; 2011 Sep; 164(2b):419-32. PubMed ID: 21449979
[TBL] [Abstract][Full Text] [Related]
4. Contribution of haemodynamic side effects and associated autonomic reflexes to ventricular arrhythmias triggering by torsadogenic hERG blocking drugs.
Champéroux P; Fares R; Bastogne T; Richard S; Le Guennec JY; Thireau J
Br J Pharmacol; 2022 Sep; 179(18):4549-4562. PubMed ID: 35751378
[TBL] [Abstract][Full Text] [Related]
5. New Insights into Ion Channels: Predicting hERG-Drug Interactions.
Wempe MF
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142644
[TBL] [Abstract][Full Text] [Related]
6. Computational and experimental studies on the inhibitory mechanism of hydroxychloroquine on hERG.
Yu R; Li P
Toxicology; 2021 Jun; 458():152822. PubMed ID: 34058295
[TBL] [Abstract][Full Text] [Related]
7. Determination of five positive control drugs in hERG external solution (buffer) by LC-MS/MS to support in vitro hERG assay as recommended by ICH S7B.
King TI; Indapurkar A; Tariq I; DePalma R; Mistry S; Alvarez-Baron C; Ismaiel OA; Wu W; Chiu K; Patel V; Rouse R; Strauss DG; Matta MK
J Pharmacol Toxicol Methods; 2022; 118():107229. PubMed ID: 36334898
[TBL] [Abstract][Full Text] [Related]
8. Novel intramolecular photoinduced electron transfer-based probe for the Human Ether-a-go-go-Related Gene (hERG) potassium channel.
Liu Z; Zhou Y; Du L; Li M
Analyst; 2015 Dec; 140(24):8101-8. PubMed ID: 26526230
[TBL] [Abstract][Full Text] [Related]
9. Prediction of hERG Liability - Using SVM Classification, Bootstrapping and Jackknifing.
Sun H; Huang R; Xia M; Shahane S; Southall N; Wang Y
Mol Inform; 2017 Apr; 36(4):. PubMed ID: 28000393
[TBL] [Abstract][Full Text] [Related]
10. Prediction of Thorough QT study results using action potential simulations based on ion channel screens.
Mirams GR; Davies MR; Brough SJ; Bridgland-Taylor MH; Cui Y; Gavaghan DJ; Abi-Gerges N
J Pharmacol Toxicol Methods; 2014; 70(3):246-54. PubMed ID: 25087753
[TBL] [Abstract][Full Text] [Related]
11. Cell-Based hERG Channel Inhibition Assay in High-Throughput Format.
Zhao J; Xia M
Methods Mol Biol; 2022; 2474():21-28. PubMed ID: 35294752
[TBL] [Abstract][Full Text] [Related]
12. P-Glycoprotein-Mediated Interaction Is a Risk Factor for QT Prolongation in Concomitant Use of Antipsychotics and SSRIs as P-Glycoprotein-Mediated Inhibitors: Analysis of the Japanese Adverse Drug Event Report Database.
Morishita H; Perera LMB; Sunakawa H; Kimura S; Yoshida H; Ogihara T
J Clin Pharmacol; 2024 Jan; 64(1):118-124. PubMed ID: 37658631
[TBL] [Abstract][Full Text] [Related]
13. A High-Throughput Screening Assay to Identify Drugs that Can Treat Long QT Syndrome Caused by Trafficking-Deficient K
Egly CL; Blackwell DJ; Schmeckpeper J; Delisle BP; Weaver CD; Knollmann BC
Mol Pharmacol; 2022 Apr; 101(4):236-245. PubMed ID: 35125346
[TBL] [Abstract][Full Text] [Related]
14. Use of automated patch clamp in cardiac safety assessment: Past, present & future perspectives.
Bell DC; Fermini B
J Pharmacol Toxicol Methods; 2021; 111():107114. PubMed ID: 34400309
[TBL] [Abstract][Full Text] [Related]
15. Neurotoxic and cardiotoxic effects of
Jeong S; Yoon KS; Lee JM; Jo ES; Kim D; Choi SO
Drug Chem Toxicol; 2023 May; 46(3):430-440. PubMed ID: 35296205
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence Anisotropy-Based Assay for Characterization of Ligand Binding Dynamics to GPCRs: The Case of Cy3B-Labeled Ligands Binding to MC
Veiksina S; Tahk MJ; Laasfeld T; Link R; Kopanchuk S; Rinken A
Methods Mol Biol; 2021; 2268():119-136. PubMed ID: 34085265
[TBL] [Abstract][Full Text] [Related]
17. Prediction of hERG inhibition of drug discovery compounds using biomimetic HPLC measurements.
Stergiopoulos C; Tsopelas F; Valko K
ADMET DMPK; 2021; 9(3):191-207. PubMed ID: 35300361
[TBL] [Abstract][Full Text] [Related]
18. Impact of antipsychotics and antidepressants drugs on long QT syndrome induction related to hERG channel dysfunction: A systematic review.
Nemati M; Hosseinzadeh Z; Nemati F; Ebrahimi B
Biochem Biophys Res Commun; 2023 Nov; 681():90-96. PubMed ID: 37774574
[TBL] [Abstract][Full Text] [Related]
19. CardioTox net: a robust predictor for hERG channel blockade based on deep learning meta-feature ensembles.
Karim A; Lee M; Balle T; Sattar A
J Cheminform; 2021 Aug; 13(1):60. PubMed ID: 34399849
[TBL] [Abstract][Full Text] [Related]
20. High-Throughput Chemical Screening and Structure-Based Models to Predict hERG Inhibition.
Krishna S; Borrel A; Huang R; Zhao J; Xia M; Kleinstreuer N
Biology (Basel); 2022 Jan; 11(2):. PubMed ID: 35205076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
